Peer Review History

Original SubmissionMarch 31, 2022
Decision Letter - Theodoros M. Bampouras, Editor

PONE-D-22-09461Muscle contractile exercise through a belt electrode device prevents myofiber atrophy, muscle contracture, and muscular pain in immobilized rat gastrocnemius musclePLOS ONE

Dear Dr. Honda,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

You will see that the reviewers have raised a range of concerns (please further below), from minor aspects on formatting to more substantial aspects on methodological clarity and approaches, which could alter the results and their interpretation. Therefore, I would invite you to carefully consider each comment and address it appropriately.  

Please submit your revised manuscript by Aug 09 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Theodoros M. Bampouras

Academic Editor

PLOS ONE

Journal Requirements: 

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Dear Editor,

Re: "Muscle contractile exercise through a belt electrode device prevents myofiber atrophy, muscle contracture, and muscular pain in immobilized rat gastrocnemius muscle "

Thank you for my opportunity to review this manuscript. The study used the immobilized rat gastrocnemius muscle model to show the consequences of the belt electrode device on skeletal muscle. The device was used as the therapeutic method to alleviate the myofiber atrophy, muscle contracture, and muscular pain effects caused by immobilization. The objectives of the study are clearly stated, the concept and the experimental design of this study is well structured and the experiments are well conducted. However, there are points need to be addressed to increase the reliability and quality of the manuscript.

Reviewer Comments:

1. The name of the abscissa axis in Figure 1. B is wrong, and the author wants to express the stimulation time, not the stimulation intensity.

2. The special symbols for p-values denoting between-group differences in Figure 2. B and Figure 5. B do not exactly match the legends.

3. According to the author's experimental results in Figure 4. A, we found that there are only type IIb muscle fibers in the superficial gastrocnemius muscle in this experiment. How to determine that there are only type IIb muscle fibers in the superficial gastrocnemius muscle?

4. In the text, the baseline PPT of the gastrocnemius muscles in the LF group was higher than that in the immobilization group. However, in Figure 6. A, the gastrocnemius muscle baseline PPT value in the LF group was lower than in the fixed group.

Reviewer #2: This study was to test the physiological benefit of repeated muscle contractile exercise using a belt electrode device in an animal model with both ankle joints immobilization. The authors reported that myofiber atrophy, joint movement limitation, and mechanical muscle hyperalgesia were observed in immobilized rats, and muscle contractile exercise through the belt electrode device was beneficiary in preventing them. In general, the study has translational significance followed with previous studies. The method was detailed, and data were presented clearly to support the conclusion. However, there are some major comments to improve this paper before I would recommend that the paper be published. If the authors can address my concerns, I am happy to review this paper again. In addition, here are some minor essential changes needed and some suggestions to consider.

Major essential changes needed:

1. In this study, myonuclear apoptosis is mentioned as one of the mechanisms of skeletal muscle atrophy, but the involvement of muscle protein synthesis and degradation is ignored. The total and phosphorylated forms of Akt, p70S6K, and 4E-BP1 (FoxO 1/3 phosphorylation would also be informative) in each experimental group should be added as items to be examined. For example, the time course of the acute effect of a single bout of muscle contractile exercise through the belt electrode device on their phosphorylation should be investigated. In particular, Akt-mTOR signaling pathways may orchestrate both a positive protein metabolism in skeletal muscle and myonuclear apoptosis.

2. Methods. In statistical analysis for "range of motion on ankle joint dorsiflexion" and "pressure pain threshold", a split-plot ANOVA using 2 factors (time [baseline vs. 1W vs. 2W] and group [control vs. immobilization vs. LF vs. HF]) must be used to determine the interaction and main effects, after verifying the normality of the data.

Minor essential changes needed:

1. Methods. Please add the length of time between last electrical stimulation, and euthanasia and tissue collection. Exercise itself can raise macrophage accumulation, NGF upregulation, and some cytokines in tissues. This will help exercise physiology readers interpret the results compared to their own.

2. Methods. The authors described "2 sec (do)/6 sec (rest) duty cycle" as low-frequency and "2 sec (do)/2 sec (rest) duty cycle" as high-frequency for electrical stimulation conditions. It is necessary to clarify the definition of low-frequency or high-frequency in the electrical stimulation conditions.

3. Methods. To mention that 60% maximal voluntary contraction is most effective in preventing skeletal muscle atrophy, should be provided a clear link to the previous studies referenced. In general, it is defined not only by the intensity of muscle contraction exercise, but also by the number of exercises and the number of sets.

4. Methods. What is the stimulus intensity you set when you conducted the preliminary experiment to determine the stimulus time?

5. Results. For histological observation, the quality of the tissue images stained with immunohistochemistry (Figure 2A) and H&E (Figure 3) were poor in the PDF file.

Minor suggested changes:

1. Introduction. Hypotheses should be added at the end of the Introductory section.

2. Results. In lines 224 on page 10 to line 226 on page 11, "In the immobilization, LF, and HF groups..." seems to be more appropriate than "In the immobilization, LF, HF groups...".

3. Results. In lines 253-254 on page 12, “The CSA of type IIa myofibers was...” could be more accurate if change to “The CSA of type IIa myofibers in the deep region was...”.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Yun Zhou

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Revision 1

Response to the Editor-in-Chief and reviewers

We would like to thank both the reviewers for evaluating our study and their constructive criticism, which allowed us to strengthen and clarify our study's conclusions. We have responded in detail to each comment and discussed how the concerns raised were addressed in the revised manuscript.

Journal Requirements

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_ sample_title_authors_affiliations.pdf

We revised our manuscript according to The PLOS ONE style templates.

Comments to the Author

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

We submitted all data sheets (supplemental file) according to your advice.

Reviewer: 1

1. The name of the abscissa axis in Figure 1. B is wrong, and the author wants to express the stimulation time, not the stimulation intensity.

We revised Fig 1.B according to your advice.

2. The special symbols for p-values denoting between-group differences in Figure 2. B and Figure 5. B do not exactly match the legends.

We modified our legends according to your advice.

3. According to the author's experimental results in Figure 4. A, we found that there are only type IIb muscle fibers in the superficial gastrocnemius muscle in this experiment. How to determine that there are only type IIb muscle fibers in the superficial gastrocnemius muscle?

We confirmed all parts in the ATPase-stained cross-sections, and we examined the deep regions (supplement figure 1, blue square) and the superficial regions (supplement figure 1, red square) separately. From supplement figure 1, the superficial regions consisted entirely of type IIb fibers. In addition, the previous report supported this point1).

1) Kernell D, Lind A, van Diemen AB, De Haan A. Relative degree of stimulation-evoked glycogen degradation in muscle fibres of different type in rat gastrocnemius. J Physiol. 1995;484:139-153.

4. In the text, the baseline PPT of the gastrocnemius muscles in the LF group was higher than that in the immobilization group. However, in Figure 6. A, the gastrocnemius muscle baseline PPT value in the LF group was lower than in the fixed group.

We retouched the figure of PPT according to your advice.

Reviewer: 2

Major essential changes needed:

1. In this study, myonuclear apoptosis is mentioned as one of the mechanisms of skeletal muscle atrophy, but the involvement of muscle protein synthesis and degradation is ignored. The total and phosphorylated forms of Akt, p70S6K, and 4E-BP1 (FoxO 1/3 phosphorylation would also be informative) in each experimental group should be added as items to be examined. For example, the time course of the acute effect of a single bout of muscle contractile exercise through the belt electrode device on their phosphorylation should be investigated. In particular, Akt-mTOR signaling pathways may orchestrate both a positive protein metabolism in skeletal muscle and myonuclear apoptosis.

Your advice was very important. Thomason DB indicated that muscle protein degradation was more influential than muscle protein synthesis for muscle atrophy in 2-week immobilization1). Atrogin-1 and muscle RING-finger protein (MuRF)-1 as ubiquitin-proteasome pathway enzymes played a main role in muscle protein degradation2). Also, peroxisome proliferator-activated receptor gamma coactivator (PGC)-1α was the main regulator for Atrogin-1 and MuRF-13). Therefore, we examined the mRNA expression of PGC-1α, Atrogin-1, and MuRF-1. As a result, the PGC-1α mRNA expression in the immobilization and LF groups was significantly lower than that in the control group, that in the control and HF groups was no significant difference. Additionally, the Atrogin-1 and MuRF-1 mRNA expressions in the experimental groups were significantly higher than those in the control group, whereas those in the HF group were significantly lower than those in the immobilization and LF groups. From these results, muscle contractile exercise through a belt electrode device may prevent the progression of muscle protein degradation.

These contents were reflected in our manuscript.

1) Thomason DB, Booth FW. Atrophy of the soleus muscle by hindlimb unweighting. J Appl Physiol (1985). 1990;68:1-12.

2) Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. J Science. 2001;294:1704-1708.

3) Kang C, Ji LL. Muscle immobilization and remobilization downregulates PGC-1α signaling and the mitochondrial biogenesis pathway. J Appl Physiol 2013;115: 1618-1625.

2. Methods. In statistical analysis for "range of motion on ankle joint dorsiflexion" and "pressure pain threshold", a split-plot ANOVA using 2 factors (time [baseline vs. 1W vs. 2W] and group [control vs. immobilization vs. LF vs. HF]) must be used to determine the interaction and main effects, after verifying the normality of the data.

Thank you for your advice. We modified the statistical process. "range of motion on ankle joint dorsiflexion" and "pressure pain threshold" were assessed using two-way ANOVA, followed by Scheffé’s method. Differences were considered statistically significant at p < 0.05. We added these contents to our manuscript (P10, L218-219).

Minor essential changes needed:

1. Methods. Please add the length of time between last electrical stimulation, and euthanasia and tissue collection. Exercise itself can raise macrophage accumulation, NGF upregulation, and some cytokines in tissues. This will help exercise physiology readers interpret the results compared to their own.

Based on the previous study, we biopsied 12 hours after the last electrical stimulation1). We added this contents to our manuscript (P8, L169-170).

1) Tanaka M, Morifuji T, Sugimoto K, Akasaka H, Fujimoto T, Yoshikawa M, et al. Effects of combined treatment with blood flow restriction and low-current electrical stimulation on capillary regression in the soleus muscle of diabetic rats. J Appl Physiol (1985). 2021:1219-1229.

2. Methods. The authors described "2 sec (do)/6 sec (rest) duty cycle" as low-frequency and "2 sec (do)/2 sec (rest) duty cycle" as high-frequency for electrical stimulation conditions. It is necessary to clarify the definition of low-frequency or high-frequency in the electrical stimulation conditions.

Dow DE examined the effect of the difference in the number of muscle contractions on muscle atrophy1). Dow DE suggested that 200 contractions per day would be a good design choice to maintain mass, force, and fiber CSA while minimizing energy transfer that may negatively affect the tissue and decrease battery life. In our study, the LF and HF groups had 150 and 225 contractions per day. Therefore, we distinguished the 2 groups from the number of muscle contractions.

1) Dow DE, Cederna PS, Hassett CA, Kostrominova TY, Faulkner JA, Dennis RG. Number of contractions to maintain mass and force of a denervated rat muscle. Muscle Nerve. 2004;30:77-86.

3. Methods. To mention that 60% maximal voluntary contraction is most effective in preventing skeletal muscle atrophy, should be provided a clear link to the previous studies referenced. In general, it is defined not only by the intensity of muscle contraction exercise, but also by the number of exercises and the number of sets.

American College of Sports Medicine indicated that the intensity of muscle contractile exercise was one of the important factors for increasing muscle strength1). Concretely, the muscle contractile exercise in 60% MVC produced the largest effect sizes for strength increases1). Furthermore, the same report suggested that the alteration of cross-sectional areas was one of the main components to define muscle strength1). From these, we surmised that the muscle contractile exercise in 60% MVC was most effective to prevent muscle atrophy.

1) American College of Sports Medicine. American College of Sports Medicine position stand. Progression models in resistance training for healthy adults. Med Sci Sports Exerc. 2009;41:687-708.

4. Methods. What is the stimulus intensity you set when you conducted the preliminary experiment to determine the stimulus time?

We set the stimulus intensity to 4.7 mA in the preliminary experiment to determine the stimulus time.

5. Results. For histological observation, the quality of the tissue images stained with immunohistochemistry (Figure 2A) and H&E (Figure 3) were poor in the PDF file.

We modified the dpi of figure 2A and 3.

Minor suggested changes:

1. Introduction. Hypotheses should be added at the end of the Introductory section.

We revised our manuscript according to your advice.

2. Results. In lines 224 on page 10 to line 226 on page 11, "In the immobilization, LF, and HF groups..." seems to be more appropriate than "In the immobilization, LF, HF groups...".

We modified our manuscript according to your advice (P11, L225).

3. Results. In lines 253-254 on page 12, “The CSA of type IIa myofibers was...” could be more accurate if change to “The CSA of type IIa myofibers in the deep region was...”.

We retouched our manuscript according to your advice (P12, L254 and L257).

Attachments
Attachment
Submitted filename: response letter.docx
Decision Letter - Theodoros M. Bampouras, Editor

Muscle contractile exercise through a belt electrode device prevents myofiber atrophy, muscle contracture, and muscular pain in immobilized rat gastrocnemius muscle

PONE-D-22-09461R1

Dear Dr. Okita,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Theodoros M. Bampouras

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The revised version of the manuscript by Honda Y et al. has included satisfactory changes and the queries raised have also been adequately dealt with.

Reviewer #2: The authors have been very responsive to my concerns. I have no more concerns. I agree with their statements and changes in response to the other reviewers as well.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Yun Zhou

Reviewer #2: Yes: Masahiro Iwata

**********

Formally Accepted
Acceptance Letter - Theodoros M. Bampouras, Editor

PONE-D-22-09461R1

Muscle contractile exercise through a belt electrode device prevents myofiber atrophy, muscle contracture, and muscular pain in immobilized rat gastrocnemius muscle

Dear Dr. Okita:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Theodoros M. Bampouras

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .